Health

Pfizer to Discontinue Its Hemophilia B Gene Therapy

TribeNews
By TribeNews 1 View Add a Comment
0 Min Read
Pfizer to Discontinue Its Hemophilia B Gene Therapy

MedPage Today) — Less than a year after approval, Pfizer said it plans to discontinue its hemophilia B gene therapy fidanacogene elaparvovec (Beqvez) across all global markets, citing weak demand.

“Pfizer has made the decision to cease further…

- Advertisement -
Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app